AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $76,868 | -6.4% | 452,167 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $82,159 | -61.3% | 452,167 | 0.0% | 0.01% | -50.0% |
Q4 2022 | $212,473 | -25.4% | 452,167 | 0.0% | 0.01% | -14.3% |
Q3 2022 | $285,000 | -36.9% | 452,167 | 0.0% | 0.01% | -39.1% |
Q2 2022 | $452,000 | -16.8% | 452,167 | 0.0% | 0.02% | +43.8% |
Q1 2022 | $543,000 | -19.9% | 452,167 | 0.0% | 0.02% | +14.3% |
Q4 2021 | $678,000 | -8.0% | 452,167 | 0.0% | 0.01% | +55.6% |
Q3 2021 | $737,000 | -5.8% | 452,167 | 0.0% | 0.01% | -10.0% |
Q2 2021 | $782,000 | -34.5% | 452,167 | 0.0% | 0.01% | -63.0% |
Q1 2021 | $1,194,000 | +42.7% | 452,167 | 0.0% | 0.03% | +22.7% |
Q4 2020 | $837,000 | +6.4% | 452,167 | 0.0% | 0.02% | -33.3% |
Q3 2020 | $787,000 | -20.2% | 452,167 | 0.0% | 0.03% | -17.5% |
Q2 2020 | $986,000 | +50.3% | 452,167 | 0.0% | 0.04% | +17.6% |
Q1 2020 | $656,000 | -17.1% | 452,167 | 0.0% | 0.03% | -8.1% |
Q4 2019 | $791,000 | +2.3% | 452,167 | 0.0% | 0.04% | -42.2% |
Q3 2019 | $773,000 | -15.3% | 452,167 | 0.0% | 0.06% | 0.0% |
Q2 2019 | $913,000 | -43.6% | 452,167 | 0.0% | 0.06% | -23.8% |
Q1 2019 | $1,619,000 | +128.0% | 452,167 | 0.0% | 0.08% | +200.0% |
Q4 2018 | $710,000 | -38.7% | 452,167 | 0.0% | 0.03% | -44.0% |
Q3 2018 | $1,158,000 | +31.3% | 452,167 | 0.0% | 0.05% | +22.0% |
Q2 2018 | $882,000 | +7.2% | 452,167 | 0.0% | 0.04% | +10.8% |
Q1 2018 | $823,000 | -58.0% | 452,167 | 0.0% | 0.04% | -54.3% |
Q4 2017 | $1,958,000 | -29.5% | 452,167 | 0.0% | 0.08% | -16.5% |
Q3 2017 | $2,776,000 | +33.2% | 452,167 | 0.0% | 0.10% | +27.6% |
Q2 2017 | $2,084,000 | -58.4% | 452,167 | 0.0% | 0.08% | -56.3% |
Q1 2017 | $5,005,000 | +57.2% | 452,167 | 0.0% | 0.17% | +37.0% |
Q4 2016 | $3,183,000 | -17.3% | 452,167 | 0.0% | 0.13% | -26.6% |
Q3 2016 | $3,848,000 | -36.9% | 452,167 | 0.0% | 0.17% | -45.4% |
Q2 2016 | $6,100,000 | +244.8% | 452,167 | +270.7% | 0.32% | +180.5% |
Q4 2015 | $1,769,000 | +174.3% | 121,970 | +353.5% | 0.11% | +169.0% |
Q3 2015 | $645,000 | – | 26,894 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 426,297 | $2,617,000 | 0.72% |
Vivo Capital, LLC | 345,850 | $2,124,000 | 0.43% |
Hikari Power Ltd | 151,334 | $929,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 433,551 | $2,662,000 | 0.12% |
NEA Management Company, LLC | 452,167 | $2,776,000 | 0.10% |
Baker Brothers Advisors | 496,901 | $3,051,000 | 0.02% |
HUNTINGTON NATIONAL BANK | 8,000 | $49,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 115,543 | $709,000 | 0.00% |
DEUTSCHE BANK AG\ | 5,300 | $32,000 | 0.00% |
MORGAN STANLEY | 8,807 | $54,000 | 0.00% |